require_once( "../navigation.include" ); ?>
check_image( "../cid_images/cid_5824.png" ); ?>
check_image( "../cid_thumbs/cid_47054.png" ); ?>
check_image( "../cid_thumbs/cid_19887.png" ); ?>
check_image( "../cid_thumbs/cid_312558.png" ); ?>
check_image( "../cid_thumbs/cid_312555.png" ); ?>
check_image( "../cid_thumbs/cid_5281766.png" ); ?>
check_image( "../cid_thumbs/cid_8738923.png" ); ?>
check_image( "../cid_thumbs/cid_5451931.png" ); ?>
check_image( "../cid_thumbs/cid_4852118.png" ); ?>
check_image( "../cid_thumbs/cid_3557809.png" ); ?>
check_image( "../cid_thumbs/cid_4527309.png" ); ?>
check_image( "../cid_thumbs/cid_3554018.png" ); ?>
check_image( "../cid_thumbs/cid_95257.png" ); ?>
check_image( "../cid_thumbs/cid_443732.png" ); ?>
check_image( "../cid_thumbs/cid_66042.png" ); ?>
check_image( "../cid_thumbs/cid_34885.png" ); ?>
check_image( "../cid_thumbs/cid_59862.png" ); ?>
check_image( "../cid_thumbs/cid_4165317.png" ); ?>
check_image( "../cid_thumbs/cid_5348772.png" ); ?>
check_image( "../cid_thumbs/cid_373540.png" ); ?>
check_image( "../cid_thumbs/cid_4467223.png" ); ?>
check_image( "../cid_thumbs/cid_2810785.png" ); ?>
check_image( "../cid_thumbs/cid_257459.png" ); ?>
Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
pre_formula_key( "InChIKey=OSZNNLWOYWAHSS-UQMCUWGUCQ", "jqp000/5824.html" ); ?>
pre_formula( "InChI=1/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/fC12H19N2O2.CH3O4S/qm;-1", "jqp000/5824.html" ); ?>
Molecular Formula:
C13H22N2O6S
InChI: InChI=1/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/fC12H19N2O2.CH3O4S/qm;-1
InChIKey: InChIKey=OSZNNLWOYWAHSS-UQMCUWGUCQ
SMILES: CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.COS(=O)(=O)[O-]
Names:
Eustigmin methylsulfate
Hodostin
Neostigmeth
Normastigmin
Polstigmine
Proserine
Prostigmin
Synstigmine
Syntostigmin (VAN)
Syntostigmin
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium; sulfonatooxymethane
name_it( "InChI=1/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/fC12H19N2O2.CH3O4S/qm;-1", "jqp000/5824.html" ); ?>
Registries:
pre_registry_key( "InChI=1/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/fC12H19N2O2.CH3O4S/qm;-1", "InChIKey=OSZNNLWOYWAHSS-UQMCUWGUCQ", "jqp000/5824.html" ); ?>
PubChem CID 5824
PubChem ID 148616
pre_ads_key( "InChIKey=OSZNNLWOYWAHSS-UQMCUWGUCQ", "jqp000/5824.html" ); ?>
pre_ads( "InChI=1/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/fC12H19N2O2.CH3O4S/qm;-1", "jqp000/5824.html" ); ?>
require_once( "../ads.include" ); ?>
pre_related( "InChI=1/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/fC12H19N2O2.CH3O4S/qm;-1", "jqp000/5824.html" ); ?>